Aussagekraft der PAH-Clearance im Vergleich zu gebräuchlichen Laborverfahren für die Diagnose von Nierenerkrankungen der Katze

2010 ◽  
Vol 24 (8) ◽  
pp. 642-671
Author(s):  
P. Bieri
Keyword(s):  
1991 ◽  
Vol 261 (4) ◽  
pp. F726-F733 ◽  
Author(s):  
C. Battilana ◽  
H. P. Zhang ◽  
R. A. Olshen ◽  
L. Wexler ◽  
B. D. Myers

We have analyzed the efficiency with which p-amino-hippuric acid (PAH) is extracted (EPAH) by patients with healthy kidneys (n = 13) or kidneys damaged by chronic cyclosporin nephropathy (n = 21) or primary glomerulopathy (n = 12); respective values (mean +/- SE) for EPAH were 0.87 +/- 0.03, 0.77 +/- 0.03, and 0.69 +/- 0.04. Judged by a 131I-hippuran-to-PAH clearance ratio of 0.75 +/- 0.05, extraction ratio of hippuran was less efficient than EPAH in three glomerulopathic patients. A direct relationship was defined between EPAH and glomerular filtration rate (GFR) (r = 0.54) or calculated efferent oncotic pressure (IIE; r = 0.41, P less than 0.01). Curve fitting by means of quadratic spline functions revealed GFR and IIE to be additive in predicting EPAH (R2 = 0.45). Linear model prediction methods and a sample reuse technique failed to predict EPAH reliably from GFR and preglomerular oncotic pressure (IIA); however, 95% prediction intervals exceed 0.30 EPAH units in width. We conclude that oncotic pressure (presumably reflecting albumin concentration) along with GFR is predictive of EPAH depression in humans with chronic renal disease. However, even sophisticated curve-fitting techniques are too imprecise for accurate prediction of EPAH in a given individual. We submit that renal venous sampling to determine EPAH continues to be necessary for the accurate determination of the rate of plasma flow in the injured human kidney.


2014 ◽  
Vol 2 (2) ◽  
pp. e00243 ◽  
Author(s):  
Ariane Bischoff ◽  
Michael Bucher ◽  
Michael Gekle ◽  
Christoph Sauvant

1970 ◽  
Vol 63 (1) ◽  
pp. 161-174 ◽  
Author(s):  
Lave Ohlsson

ABSTRACT Clearances of inulin and para-aminohippurate (PAH) were studied before as well as three to nine years (average 5½) after surgery in 35 cases of primary hyperparathyroidism. The preoperative inulin clearance ranged from 18 to 105 (average 67) and the PAH clearance from 61 to 666 (349) ml/min/1.73 m2 BSA. In the follow-up studies clearances of inulin and PAH were, on the whole, well maintained both in subjects with normal as well as in cases showing depressed clearance values before surgery. In fact, a slight but statistically significant increase of inulin clearance was demonstrated in the material as a whole, whereas no significant change occurred in PAH clearance. The renal concentrating capacity was estimated before and after operation in 22 of the patients. An increase was almost regularly observed postoperatively but the concentrating capacity remained subnormal in almost half of the subjects studied. The changes in the concentrating capacity and clearances of inulin and PAH did not always run parallel. The renal clearance of phosphate was studied simultaneously with inulin and PAH clearances. Phosphate clearance decreased after surgery concomitantly with an elevation of serum phosphorus. However, restoration to the normal was not always obtained. Arterial hypertension was present in 40 per cent of the patients before and/or after surgery. Only grade I-II eye ground changes were found. Blood pressure was easily controlled by hypotensive drugs. A spontaneous disappearance or a decrease in the number of kidney stones was demonstrated radiologically at the follow-up studies in almost half of the patients. In only two subjects were additional kidney stones found. It is concluded that, following surgical treatment of hyperparathyroidism, the long-term outcome regarding renal function may be more favourable than has hitherto been thought.


2007 ◽  
Vol 292 (5) ◽  
pp. F1599-F1605 ◽  
Author(s):  
R. Schneider ◽  
C. Sauvant ◽  
B. Betz ◽  
M. Otremba ◽  
D. Fischer ◽  
...  

Ischemic acute renal failure (iARF) was described to reduce renal extraction of the organic anion para-aminohippurate (PAH) in humans. The rate-limiting step of renal organic anion secretion is its basolateral uptake into proximal tubular cells. This process is mediated by the organic anion transporters OAT1 and OAT3, which both have a broad spectrum of substrates including a variety of pharmaceutics and toxins. Using a rat model of iARF, we investigated whether impairing the secretion of the organic anion PAH might be associated with downregulation of OAT1 or OAT3. Inulin and PAH clearance was determined starting from 6 up to 336 h after ischemia-reperfusion (I/R) injury. Net secretion of PAH was calculated and OAT1 as well as OAT3 expression was analyzed by RT-PCR and Western blotting. Inulin and PAH clearance along with PAH net secretion were initially diminished after I/R injury with a gradual recovery during follow-up. This initial impairment after iARF was accompanied by decreased mRNA and protein levels of OAT1 and OAT3 in clamped animals compared with sham-operated controls. In correlation to the improvement of kidney function, both mRNA and protein levels of OAT1 and OAT3 were upregulated during the follow-up. Thus decreased expression of OAT1 and OAT3 is sufficient to explain the decline of PAH secretion after iARF. As a result, this may have substantial impact on excretion kinetics and half-life of organic anions. As a consequence, the biological effects of a variety of organic anions may be affected after iARF.


1964 ◽  
Vol 207 (3) ◽  
pp. 523-529 ◽  
Author(s):  
Arthur H. Weintraub ◽  
Albert S. Gordon ◽  
E. Lovell Becker ◽  
James F. Camiscoli ◽  
Joseph F. Contrera

The pattern of plasma and renal clearance of purified sheep erythropoietin (ESF) was studied in unanesthetized dogs given a single intravenous injection of the hormone. Creatinine and PAH clearance measurements were also made up to 5 hr after ESF administration. Plasma clearance of ESF was found to be essentially biphasic: half-times for an initial rapid phase (0–1 hr) ranged from 20–45 min while those for the slower phase (1–24 hr) were of the order of 9–10.5 hr. Despite the loss from the plasma compartment of up to 70% of the injected dose of ESF within 3.5 hr, urinary recovery of the factor was quite low: about 2% of the injected dose in two experiments where 1,600 units were given and about 5% in a third experiment in which a dose of 3,200 units was employed. Excretion rates of the factor were found to be uniformly low and ESF clearance ranged from 0.1 to 0.6 ml/min. Some correlation between plasma levels and excretion rate of ESF was obtained. ESF clearance represented only a small fraction (0.1–1.4%) of the glomerular filtration rate. Injection of the hormone did not markedly influence creatinine or PAH clearance.


1952 ◽  
Vol 30 (15-16) ◽  
pp. 340-343 ◽  
Author(s):  
J. Moeller ◽  
L. Abt
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document